Rottendorf Pharma is a contract development and manufacturing organization (CDMO) focused on solid oral dosage forms for the pharmaceutical industry. Founded in 1928, the company operates from its headquarters in Ennigerloh, Münsterland, Germany, with an additional office in Boston, Massachusetts. Its services span the full value chain, including pharmaceutical formulation development, analytical methods development, commercial manufacturing, and packaging.
The company positions itself as a true extension of its clients' operations and, as a foundation-owned group, does not market its own products to avoid competing with its customers. Its technical work in formulation, analytics, and manufacturing is supported by experience spanning more than 95 years and a record of passing inspections from regulatory authorities including the EMA, FDA, and ANVISA.
For technology professionals, Rottendorf Pharma's operations involve maintaining and developing the systems that support pharmaceutical development workflows, analytical data management, and manufacturing execution. The company's focus on GMP-compliant processes and its global regulatory footprint create an environment where technology work directly intersects with stringent quality and compliance requirements.
